Recombinant Human NPRL2 Protein, N-His from ProteoGenix; catalogue ARO-P12261; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant human NPRL2 protein is a highly purified and bioactive protein that is produced through recombinant DNA technology. This protein plays a crucial role in regulating the mTOR signaling pathway, which is involved in various cellular processes such as growth, metabolism, and autophagy. In this article, we will discuss the structure, activity, and applications of recombinant human NPRL2 protein.
Recombinant human NPRL2 protein is a 42 kDa protein that is composed of 376 amino acids. It contains a conserved domain known as the GATOR2 complex subunit NPRL2, which is essential for its activity. The protein also has a C-terminal domain that is responsible for its interaction with other proteins in the mTOR signaling pathway.
The recombinant protein is produced by cloning the NPRL2 gene into a suitable expression vector, which is then introduced into host cells such as E. coli or mammalian cells. The cells are then grown in culture and the protein is purified using various chromatography techniques, resulting in a highly pure and active protein.
Recombinant human NPRL2 protein acts as a positive regulator of the mTOR signaling pathway. It forms a complex with other proteins, including NPRL3 and DEPDC5, to form the GATOR2 complex. This complex is responsible for inhibiting the activity of the GATOR1 complex, which is a negative regulator of mTOR signaling.
The mTOR signaling pathway is involved in various cellular processes such as cell growth, proliferation, and survival. By regulating this pathway, recombinant human NPRL2 protein plays a crucial role in maintaining cellular homeostasis and preventing diseases such as cancer and metabolic disorders.
Recombinant human NPRL2 protein has various applications in both research and therapeutic settings. Its role in regulating the mTOR signaling pathway makes it a valuable tool for studying cellular processes and diseases related to this pathway.
In research, recombinant human NPRL2 protein can be used to study the effects of mTOR signaling on cell growth, metabolism, and autophagy. It can also be used to investigate the role of this pathway in diseases such as cancer and neurodegenerative disorders.
In therapeutic settings, recombinant human NPRL2 protein has the potential to be used as a target for drug development. By modulating the activity of this protein, it may be possible to treat diseases that are associated with dysregulation of the mTOR signaling pathway.
Recombinant human NPRL2 protein is a bioactive protein that plays a crucial role in regulating the mTOR signaling pathway. Its structure, activity, and applications make it a valuable tool for research and a potential target for drug development. Further studies on this protein may provide insights into its role in various diseases and lead to the development of novel therapeutic strategies.
Recombinant protein, antigen, NPRL2, mTOR signaling pathway, GATOR2 complex, cellular processes, cancer, drug development.
ProteoGenix catalogue number ARO-P12261. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 19.99 kDa; Fragment: Arg6-Glu161; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
